Report overview
An artificial lung (AL) is a prosthetic device that provides oxygenation of blood and removal of carbon dioxide from the blood. The AL is intended to take over some of the functionality of biological lungs.
This report contains market size and forecasts of Artificial Lung in global, including the following market information:
Global Artificial Lung Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Artificial Lung Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Artificial Lung companies in 2021 (%)
The global Artificial Lung market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bubble Artificial Lung Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Lung include ALung Technologies, Breethe, Haemair, Lung Biotechnology PBC, McGowan Institute for Regenerative Medicine, MedArray, Michigan Critical Care Consultants, Miromatrix Medical and The Charles Stark Draper Laboratory and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artificial Lung manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Lung Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Lung Market Segment Percentages, by Type, 2021 (%)
Bubble Artificial Lung
Membrane Artificial Lung
Global Artificial Lung Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Lung Market Segment Percentages, by Application, 2021 (%)
Hospital
Emergency Center
Other
Global Artificial Lung Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Lung Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Lung revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Artificial Lung revenues share in global market, 2021 (%)
Key companies Artificial Lung sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Artificial Lung sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ALung Technologies
Breethe
Haemair
Lung Biotechnology PBC
McGowan Institute for Regenerative Medicine
MedArray
Michigan Critical Care Consultants
Miromatrix Medical
The Charles Stark Draper Laboratory
Xenios
